Ticker > Company >

Divi''s Lab share price

Divi''s Laboratories Ltd.

NSE: DIVISLAB BSE: 532488 SECTOR: Pharmaceuticals & Drugs  418k   2k   690

6709.90
-8.60 (-0.13%)
BSE: 12 Jun 04:01 PM

Price Summary

Today's High

₹ 6859.8

Today's Low

₹ 6700.8

52 Week High

₹ 6767

52 Week Low

₹ 4396.6

FinStar

Ownership Stable
Ownership strength is slightly missing the benchmark.
ValuationExpensive
The stock is at a premium valuation at this point.
EfficiencyExcellent
The company knows very well the utilization of its assets.
FinancialsVery Stable
The company possesses stable growth history and manageable debt.
*It is just an analytical rating of the company and not an investment advice.

Company Essentials

Market Cap

178126.76 Cr.

Enterprise Value

174165.76 Cr.

No. of Shares

26.55 Cr.

P/E

80.64

P/B

11.96

Face Value

₹ 2

Div. Yield

0.45 %

Book Value (TTM)

₹  561.09

CASH

3961 Cr.

DEBT

0 Cr.

Promoter Holding

51.89 %

EPS (TTM)

₹  83.21

Sales Growth

0.52%

ROE

12.04 %

ROCE

16.31%

Profit Growth

-12.83 %

* Total debt includes long term borrowing, short term borrowing plus current maturities of long-term borrowing
* Ratios are based on latest Audited Financial Result.

Your Added Ratios

Please login to Add & View your own added ratios.

Login

Brands

These are the brands of Divi''s Laboratories Ltd.

Carotenoids Lutein Beta-Carotene Naproxen Dextromethorphan Gabapentin

Price Chart 1d 1w 1m 3m 6m 1Yr 3Yr 5Yr

 

Volume Chart 1d 1w 1m 3m 6m 1Yr 3Yr 5Yr

* Prices are based on daily market changes.
* The chart is based on the standalone earnings of the company. * Negative values and values more than 1000x in PE chart is considered 0.

Peer Comparison

View Full Peer Comparison
* The Peers list includes companies operating in the same industry and having comparable market cap.

 Group Companies

Track the companies of Group.

Ratios

Sales Growth

1 Year0.52%
3 Year4.08%
5 Year9.45%

Profit Growth

1 Year-12.83%
3 Year-6.93%
5 Year3.41%

ROE%

1 Year12.04%
3 Year18.33%
5 Year19.55%

ROCE %

1 Year16.31%
3 Year23.57%
5 Year25.52%

Debt/Equity

0

Price to Cash Flow

140.7

Interest Cover Ratio

534

CFO/PAT (5 Yr. Avg.)

0.908768867812219

Shareholding Pattern

Promoter Pledging %

Date Promoter % Pledge %
Mar 2025 51.89 0.00
Dec 2024 51.89 0.00
Sep 2024 51.89 0.00
Jun 2024 51.90 0.00
Mar 2024 51.92 0.00
Investors List
* Figures given above are % of equity capital

 Strengths

  • Company has been maintaining healthy ROCE of 23.5729768460423% over the past 3 years.
  • Company is virtually debt free.
  • Company has a healthy Interest coverage ratio of 534.
  • The Company has been maintaining an effective average operating margins of 35.4835692091581% in the last 5 years.
  • Company has a healthy liquidity position with current ratio of 5.8052.
  • The company has a high promoter holding of 51.89%.

 Limitations

  • The company has shown a poor profit growth of -6.92696294811399% for the Past 3 years.
  • The company has shown a poor revenue growth of 4.07917390954788% for the Past 3 years.
  • The company is trading at a high PE of 80.64.
  • The company is trading at a high EV/EBITDA of 52.3665.

Quarterly Result (All Figures in Cr.)

PARTICULARS Mar 2024 Jun 2024 Sep 2024 Dec 2024 Mar 2025
Net Sales 2259 2063 2302 2297 2536
Total Expenditure 1542 1442 1573 1550 1655
Operating Profit 717 621 729 747 881
Other Income 79 79 105 82 87
Interest 2 0 1 0 0
Depreciation 94 97 98 99 107
Exceptional Items 0 0 0 0 0
Profit Before Tax 700 603 735 730 861
Tax 169 173 217 136 194
Profit After Tax 531 430 518 594 667
Adjusted EPS (Rs) 20.04 16.23 19.55 22.42 25.17

Profit & Loss (All Figures in Cr. Adjusted EPS in Rs.)

PARTICULARS Mar 2020 Mar 2021 Mar 2022 Mar 2023 Mar 2024
Net Sales 5310.57 6798.61 8879.82 7625 7665
Total Expenditure 3494.16 3977.73 5005.05 5276 5490
Operating Profit 1816.41 2820.88 3874.77 2349 2175
Other Income 189.86 63.45 114.03 349 337
Interest 7.03 1.81 1.73 2 4
Depreciation 185.95 254.65 310.55 342 376
Exceptional Items 0 0 0 0 0
Profit Before Tax 1813.29 2627.87 3676.52 2354 2132
Tax 440.58 673.15 727.98 546 556
Net Profit 1372.71 1954.72 2948.54 1808 1576
Adjusted EPS (Rs.) 51.71 73.64 111.08 68.23 59.47

Balance Sheet (All Figures are in Crores.)

Particulars Mar 2020 Mar 2021 Mar 2022 Mar 2023 Mar 2024
Equity and Liabilities
Share Capital 53.09 53.09 53.09 53 53
Total Reserves 7263.6 9218.48 11638.26 12652 13431
Borrowings 0 0 0 0 0
Other N/C liabilities 294.48 363.48 448.11 568 619
Current liabilities 1796.64 1704.78 2427.29 1511 1730
Total Liabilities 9407.81 11339.83 14566.75 14784 15833
Assets
Net Block 2776.26 3699.01 4320.97 4719 4737
Capital WIP 919.69 710.62 469.93 212 778
Intangible WIP 0 0 0 0 0
Investments 7.37 7.37 79.37 84 89
Loans & Advances 144.18 172.42 133.58 97 176
Other N/C Assets 5.44 9.21 8.05 4 10
Current Assets 5554.87 6741.2 9554.85 9668 10043
Total Assets 9407.81 11339.83 14566.75 14784 15833
* Other Non-current Liabilities include Net deferred Liabilities

Cash Flows (All Figures are in Crores.)

PARTICULARS Mar 2020 Mar 2021 Mar 2022 Mar 2023 Mar 2024
Profit from operations 1813.29 2627.87 3676.52 2354 2132
Adjustment 52.55 186.66 235.32 118 72
Changes in Assets & Liabilities -211.4 -234.52 -1371.89 447 -565
Tax Paid -445.97 -632.96 -629.79 -472 -373
Operating Cash Flow 1208.47 1947.05 1910.16 2447 1266
Investing Cash Flow -81.38 75.34 -2195.4 -2707 -268
Financing Cash Flow -1091.25 -33.97 -531.5 -796 -798
Net Cash Flow 35.84 1988.42 -816.74 -1056 200

Corporate Actions

Investors Details

PARTICULARS Mar 2024% Jun 2024% Sep 2024% Dec 2024% Mar 2025%
promoters 51.92 51.90 51.89 51.89 51.89
madhusudana rao divi 0.10 0.08 0.07 0.07 0.07
murali krishna prasad div... 2.85 2.85 2.85 2.85 2.85
nilima prasad divi 20.34 20.34 20.34 20.34 20.34
satchandra kiran divi 20.34 20.34 20.34 20.34 20.34
swarna latha divi 5.27 5.27 5.27 5.27 5.27
PARTICULARS Mar 2024% Jun 2024% Sep 2024% Dec 2024% Mar 2025%
investors 48.08 48.10 48.11 48.11 48.11
axis mutual fund trustee ... 1.69 1.60 1.50 1.39 1.39
government of singapore - - 1.77 2.38 2.26
government pension fund g... 1.23 1.63 1.53 1.34 1.32
investor education and pr... - - 0.01 - 0.01
life insurance corporatio... 6.09 6.73 6.95 6.03 5.63
nippon life india trustee... - 1.07 1.18 1.18 1.20
sbi mutual fund 7.85 7.41 5.65 5.36 4.97
investor education and pr... 0.01 0.01 - 0.01 -

Additional Resources & References

No Annual reports exist for this company.Report us

Company News

Divi''s Lab Stock Price Analysis and Quick Research Report. Is Divi''s Lab an attractive stock to invest in?

The Indian healthcare sector is expected to reach US$ 372 billion by 2022, driven by rising incomes, greater health awareness, lifestyle diseases and increasing access to insurance. Healthcare has become one of India’s largest sectors - both in terms of revenue and employment.

Healthcare comprises hospitals, medical devices, clinical trials, outsourcing, telemedicine, medical tourism, health insurance, and medical equipment. The structure of the healthcare delivery system in India consists of three broad segments: Primary care, Secondary care, and Tertiary care.

  • Primary care is the first point of contact between the population and the healthcare service providers. For example, Sub-center (SC), Primary Health Centre (PHC) and Community Health Centre (CHC) which is more relevant to rural areas (PHC’s).
  • Secondary care providers inpatient as well as outpatient medical services and includes simple surgical procedures. For example, District level & Mid-sized hospitals.
  • Tertiary care is the third level of the healthcare delivery system in the country. These hospitals are specialized consultative healthcare infrastructure. For example, Single specialty and Multi-specialty hospitals.

While healthcare services are offered by the public as well as private sectors, in urban as well as rural areas, generally people prefer private hospitals over public hospitals for treatment of diseases, illness, and sickness. So, let’s look into Divi''s Lab and its performance over the period of time. Divi''s Lab stock price today is Rs 6725.

  • Operating cash flow ratio: It measures the adequacy of a company’s cash generated from operating activities to pay off short-term financial obligations. Divi''s Lab cash from the operating activity was Rs 1266 Cr.
     
  • Financial Strength: Health care organizations usually have high debt loads and low equity capital in their balance sheet. So, Debt to Equity ratio is important to analyze the company’s sustainability. Divi''s Lab has a Debt to Equity ratio of 0 , which is a strong indication for the company.
     
  • EPS growth: Investors should ensure the EPS figure is growing faster than revenue numbers because it indicates company management is increasing the efficiency with which it runs the company. In Divi''s Lab , the EPS growth was -12.8318 % which is bad for the company.
     
  • Operating profit margin: It determines a company's potential earnings. It assesses how well-managed a company with respect to its basic overhead costs and other operating expenses, Divi''s Lab has OPM of 28.3757338551859 % which is a good sign for profitability.
     
  • ROE: Divi''s Lab have a average ROE of 12.0356 %. ROE is an important financial parameter for hospitals & health care companies because they expand and grow rapidly. Therefore, ROE measures how efficiently a shareholder's fund is used for generating profits.
     
  • Share Price: - The current share price of Divi''s Lab is Rs 6725. One can use valuation calculators of ticker to know if Divi''s Lab share price is undervalued or overvalued.
Last Updated on:
Brief about Divi''s Lab
X